Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of PA1010 in Healthy Chinese Subjects
NCT05468060Phase 1Completed
- Sponsor
- Apeloa
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of PA1010 in Chronic Hepatitis B (CHB) (8 arms), sponsored by Apeloa. Primary endpoints: Number of subjects experiencing adverse events, Number of subjects having abnormal hematology laboratory parameters and 8 more. Started Jun 2020; status: completed.
02
Drugs
PA1010
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05468060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468060.